tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

IMNM Stock Latest News

Immunome: Best-in-Class Varegacestat Data and Deep ADC Pipeline Support Buy Rating and Favorable Risk‑Reward
RatingsImmunome: Best-in-Class Varegacestat Data and Deep ADC Pipeline Support Buy Rating and Favorable Risk‑Reward
9d ago
IMNM
Immunome price target lowered to $30 from $32 at Lake Street
PremiumThe Fly
Immunome price target lowered to $30 from $32 at Lake Street
14d ago
IMNM
Immunome price target raised to $36 from $33 at Craig-Hallum
PremiumThe Fly
Immunome price target raised to $36 from $33 at Craig-Hallum
15d ago
IMNM
Immunome price target lowered to $30 from $33 at Stephens
PremiumThe Fly
Immunome price target lowered to $30 from $33 at Stephens
15d ago
IMNM
Immunome price target raised to $39 from $35 at JPMorgan
PremiumThe Fly
Immunome price target raised to $39 from $35 at JPMorgan
15d ago
IMNM
Immunome: Buy Rating on Best-in-Class Varegacestat Opportunity and Differentiated Next-Generation ADC Oncology Platform
PremiumRatingsImmunome: Buy Rating on Best-in-Class Varegacestat Opportunity and Differentiated Next-Generation ADC Oncology Platform
15d ago
IMNM
Immunome reports FY25 EPS ($2.43), consensus ($2.21)
Premium
The Fly
Immunome reports FY25 EPS ($2.43), consensus ($2.21)
16d ago
IMNM
Immunome: Advancing Best-in-Class Varegacestat and a Data-Driven ADC Pipeline Support Buy Rating and $40 Target
Premium
Ratings
Immunome: Advancing Best-in-Class Varegacestat and a Data-Driven ADC Pipeline Support Buy Rating and $40 Target
1M ago
IMNM
Shopify upgraded, Coinbase downgraded: Wall Street’s top analyst calls
PremiumThe Fly
Shopify upgraded, Coinbase downgraded: Wall Street’s top analyst calls
1M ago
ON
ADI
Immunome: Differentiated Oncology Portfolio and ADC Platform Underpin Buy Rating and $40 Price Target
PremiumRatings
Immunome: Differentiated Oncology Portfolio and ADC Platform Underpin Buy Rating and $40 Price Target
1M ago
IMNM
Immunome initiated with a Buy at H.C. Wainwright
PremiumThe Fly
Immunome initiated with a Buy at H.C. Wainwright
1M ago
IMNM
Immunome Announces Follow-On Public Offering Pricing
PremiumCompany Announcements
Immunome Announces Follow-On Public Offering Pricing
3M ago
8K
IMNM
Midday Fly By: Warner Bros. urges investors to reject Paramount bid
PremiumThe FlyMidday Fly By: Warner Bros. urges investors to reject Paramount bid
3M ago
PG
ABM
Immunome falls -7.2%
Premium
The Fly
Immunome falls -7.2%
3M ago
IMNM
Immunome 18.625M share Spot Secondary priced at $21.50
Premium
The Fly
Immunome 18.625M share Spot Secondary priced at $21.50
3M ago
IMNM
Immunome price target raised to $32 from $22 at Lake Street
PremiumThe Fly
Immunome price target raised to $32 from $22 at Lake Street
3M ago
IMNM
Immunome price target raised to $40 from $18 at Evercore ISI
PremiumThe Fly
Immunome price target raised to $40 from $18 at Evercore ISI
3M ago
IMNM
Immunome price target raised to $35 from $25 at Guggenheim
PremiumThe Fly
Immunome price target raised to $35 from $25 at Guggenheim
3M ago
IMNM
3 ‘Strong Buy’ Biotech Stocks to Buy Now, According to Top Analysts
PremiumMarket News
3 ‘Strong Buy’ Biotech Stocks to Buy Now, According to Top Analysts
3M ago
IMNM
KYTX
Immunome offers to sell $400M in common stock
PremiumThe FlyImmunome offers to sell $400M in common stock
3M ago
IMNM
Immunome’s Promising Outlook: Buy Rating Affirmed on Varegacestat’s Phase 3 Success and Strong Management
Premium
Ratings
Immunome’s Promising Outlook: Buy Rating Affirmed on Varegacestat’s Phase 3 Success and Strong Management
3M ago
IMNM
Immunome price target raised to $40 from $38 at Leerink
Premium
The Fly
Immunome price target raised to $40 from $38 at Leerink
3M ago
IMNM

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >